Methods and pharmaceutical compositions for the treatment and the prevention of alzheimers disease
US-2026007706-A1 · Jan 8, 2026 · US
This page is not indexed by search engines while we improve data quality.
Crystal Ronald G patents
Crystal Ronald G is listed as an inventor on 44 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Crystal Ronald G |
| Total patents | 44 |
| First publication | Feb 26, 2015 |
| Latest publication | Jan 8, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxia
US-2025161483-A1 · May 22, 2025 · US
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure
US-2025109407-A1 · Apr 3, 2025 · US
Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
US-2025109408-A1 · Apr 3, 2025 · US
Gene therapy for eosinophilic disorders
US-12226492-B2 · Feb 18, 2025 · US
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
US-12122844-B2 · Oct 22, 2024 · US
Development of a highly efficient second generation fentanyl-conjugate vaccine to treat fentanyl addiction
US-2024307517-A1 · Sep 19, 2024 · US
Oxidation-resistant AAT gene therapy
US-12031144-B2 · Jul 9, 2024 · US
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
US-12024568-B2 · Jul 2, 2024 · US
Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector delivery
US-11821009-B2 · Nov 21, 2023 · US
Recent patents
Latest publications not already listed above.
Methods for modulating level of expression from gene therapy expression cassette
US-2023313223-A1 · Oct 5, 2023 · US
Apoe gene therapy
US-2023044351-A1 · Feb 9, 2023 · US
Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
US-2022088143-A1 · Mar 24, 2022 · US
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure
US-2022090128-A1 · Mar 24, 2022 · US
Gene therapy for oxidative stress
US-2021381002-A1 · Dec 9, 2021 · US
Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
US-2021340565-A1 · Nov 4, 2021 · US
Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies
US-2021171656-A1 · Jun 10, 2021 · US
Adenoassociated viral mediated persistant anti-VEGF therapy for ovarian cancer
US-10946094-B2 · Mar 16, 2021 · US
Gene therapy for eosinophilic disorders
US-2020330608-A1 · Oct 22, 2020 · US
Gene therapy for alzheimer's and other neurodegenerative diseases and conditions
US-2020172605-A1 · Jun 4, 2020 · US
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure
US-2020157564-A1 · May 21, 2020 · US
Genetic modification of the aav capsid resulting in altered tropism and enhanced vector delivery
US-2020032220-A1 · Jan 30, 2020 · US
Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
US-2019358297-A1 · Nov 28, 2019 · US
Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardium
US-10383916-B2 · Aug 20, 2019 · US
Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxia
US-10337027-B2 · Jul 2, 2019 · US
Gene therapy for the treatment of aldehyde dehydrogenase deficiency
US-2019160187-A1 · May 30, 2019 · US
Gene therapy to prevent reactions to allergens
US-10293059-B2 · May 21, 2019 · US
Adeno-associated virus mediated delivery of c1ei as a therapy for angioedema
US-2019119653-A1 · Apr 25, 2019 · US
Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedema
US-10214731-B2 · Feb 26, 2019 · US
Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
US-2018334687-A1 · Nov 22, 2018 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Cornell | 44 |
| Centre Nat Rech Scient | 11 |
| Inst Nat Sante Rech Med | 10 |
| Univ Strasbourg | 10 |
| Assist Publique Hopitaux Paris Aphp | 7 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2750/14143 | 32 |
| A61K48/005 | 31 |
| C12N15/86 | 29 |
| A61K48/00 | 24 |
| C12N7/00 | 19 |